The research activities of the Gynecologic Oncology Group of Oncology 2 Unit is focused on the treatment of patients with tumor of ovarian, fallopian tube, and primary peritoneal cancers, endometrial and cervical cancers. Through the development and the participation to innovative clinical and translational studies, it aims to improve knowledge of the biology of these disease as well as patients’ outcome and quality of life.
The results of these activities have contributed to some of the most relevant progress in the treatment of these tumors in the last years, presented in the main national and international conferences and published in peer-reviewed scientific journals.
The Group is member of Associazione Italiana Oncologia Medica – AIOM, European Society of Medical Oncology – ESMO, American Association of Clinical Oncology – ASCO, European Society of Gynaecological Oncology – ESGO.
The Group collaborates with the research initiatives of MaNGO (Mario Negri Gynecologic Oncology group) and MITO (Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies).